Dalton Pharma, Lehigh expand facilities; AMRI gets NIH grant; Akor, Aurobindo, Par recall products;

> Lehigh Valley Technologies in Allentown, PA, has received a $2.25 million state loan to help with a $5 million expansion that will allow it to add 52 new full-time jobs to its existing staff of 36. Story

> Dalton Pharma in North York, Ottawa, Canada, is getting a $2 million grant towards its $8.3 million expansion project, that will allow it to add to its 70-person workforce. Story

> AMRI ($AMRI) has gotten a $37.7 million, 10-year contract through the U.S. National Institute of Health Drug Manufacturing and Formulation Program (DMFP). Release

> Akorn ($AKRX) is recalling some of its triamcinolone acetonide lotion for failing impurities testing. Recall

> Aurobindo Pharma has recalled 24,816 bottles of gabapentin capsules after receiving complaints of empty capsules. Recall

> Par Pharmaceutical is recalling 38,788 bottles of hydralazine hydrochloride tablets after aluminum particles were found in some. Recall

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

Pricing controversies shouldn't overshadow Phlow's promise to provide low-cost drugs to address COVID-19, says the CEO of partner Civica Rx.